AWA Point
Category: Insights
EPO launches new PPH agreements with New Zealand and Bahrain
The PPH network continues to expand, and we at AWA remain one step ahead by closely monitoring the new
Increasing Burden of Proof for Trademark Applicants in China
Based on the recent official notices issued by the CNIPA (China National Intellectual Property Administration) about non-use cancellation cases,
Companies with IP generate at least 23.8% more revenue according to latest EU report
The report ‘The Intellectual Property Rights and Firm Performance in the European Union’ was published last month and analyses
European Commission reports show misuse of divisionals can in itself contravene EU law
In November last year, I was interviewed about the European Commission’s €462.6 million fine against pharmaceutical giant Teva and
IP Enforcement Strategies: Combating Counterfeiting in Southeast Asia and China
Counterfeiting remains among the most significant threats to intellectual property rights globally, particularly in Southeast Asia and China. These
How foreign applicants can take advantage of China’s updated patent regime
China implemented the fourth amendment to its Patent Law, which came into effect on 1 July 2021. The amended
CNIPA releases detailed guidelines on trademark licences
China’s Trademark Law stipulates that, when granting others the right to use registered trademarks, the licensor must record the
New rules for medical devices and in vitro diagnostic medical devices
In recent years, several new and amended requirements have been introduced for medical devices and in vitro diagnostic devices
Danish Copyright Act – You may (still) lawfully use copyrighted works for parody purposes
An amendment to the Danish Copyright Act will enter into force on July 1, 2024. The amendment codifies a